Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What information is available on company profile pages?

Company profile pages provide comprehensive information including financial statements, earnings data, analyst ratings, institutional ownership, insider trading, SEC filings, and detailed business analysis.

How do I analyze a company's financial health?

Use our financial metrics including P/E ratio, debt-to-equity, revenue growth, profit margins, and cash flow analysis to evaluate a company's financial strength and growth potential.

How do I analyze NVAX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate NVAX investment potential.

What is NVAX stock price today?

The current NVAX stock price is $6.91 as of 09 Dec '25. Get real-time NVAX stock price, historical data, and price charts on Financhill.

Is NVAX a good investment?

Evaluate NVAX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

What does Novavax, Inc. (NVAX) do?

Novavax, Inc. (NVAX) is a publicly traded company. View detailed company information, business model, financial statements, and corporate data on our NVAX company profile page.

How to buy NVAX stock?

To buy NVAX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of NVAX?

View detailed market capitalization data and company valuation metrics for NVAX on our comprehensive analysis page.

What is the P/E ratio of NVAX?

Use our fundamental analysis tools to view NVAX P/E ratio and compare valuation metrics with industry peers.

What are NVAX earnings?

View NVAX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Sell

32

NVAX Quote, Financials, Valuation and Earnings

Last price:

$6.79

Seasonality move :

6.62%

Day range:

$6.66 - $7.04

52-week range:

$5.01 - $11.55

Dividend yield:

0%

P/E ratio:

3.91x

P/S ratio:

1.10x

P/B ratio:

32.13x

Volume:

3.7M

Avg. volume:

3.8M

1-year change:

-16.75%

Market cap:

$1.1B

Revenue:

$682.2M

EPS (TTM):

$1.77

Novavax, Inc. SEC Filings

Company	Filed	Form Type	Description
NVAX Novavax, Inc.	05/10/2024	10-Q	10-Q filing on 05/10/2024	View Form
NVAX Novavax, Inc.	02/28/2024	10-K	10-K filing on 02/28/2024	View Form
NVAX Novavax, Inc.	11/09/2023	10-Q	10-Q filing on 11/09/2023	View Form
NVAX Novavax, Inc.	08/08/2023	10-Q	10-Q filing on 08/08/2023	View Form
NVAX Novavax, Inc.	05/09/2023	10-Q	10-Q filing on 05/09/2023	View Form
NVAX Novavax, Inc.	02/28/2023	10-K	10-K filing on 02/28/2023	View Form
NVAX Novavax, Inc.	11/09/2022	10-Q	10-Q filing on 11/09/2022	View Form
NVAX Novavax, Inc.	08/09/2022	10-Q	10-Q filing on 08/09/2022	View Form
NVAX Novavax, Inc.	05/10/2022	10-Q	10-Q filing on 05/10/2022	View Form
NVAX Novavax, Inc.	03/01/2022	10-K	10-K filing on 03/01/2022	View Form
NVAX Novavax, Inc.	11/05/2021	10-Q	10-Q filing on 11/05/2021	View Form
NVAX Novavax, Inc.	08/05/2021	10-Q	10-Q filing on 08/05/2021	View Form
NVAX Novavax, Inc.	05/10/2021	10-Q	10-Q filing on 05/10/2021	View Form
NVAX Novavax, Inc.	04/30/2021	10-K	10-K filing on 04/30/2021	View Form
NVAX Novavax, Inc.	03/01/2021	10-K	10-K filing on 03/01/2021	View Form
NVAX Novavax, Inc.	11/10/2020	10-Q	10-Q filing on 11/10/2020	View Form
NVAX Novavax, Inc.	08/10/2020	10-Q	10-Q filing on 08/10/2020	View Form
NVAX Novavax, Inc.	05/11/2020	10-Q	10-Q filing on 05/11/2020	View Form
NVAX Novavax, Inc.	04/29/2020	10-K	10-K filing on 04/29/2020	View Form
NVAX Novavax, Inc.	03/11/2020	10-K	10-K filing on 03/11/2020	View Form
NVAX Novavax, Inc.	11/07/2019	10-Q	10-Q filing on 11/07/2019	View Form
NVAX Novavax, Inc.	08/07/2019	10-Q	10-Q filing on 08/07/2019	View Form
NVAX Novavax, Inc.	05/02/2019	10-Q	10-Q filing on 05/02/2019	View Form
NVAX Novavax, Inc.	04/30/2019	10-K	10-K filing on 04/30/2019	View Form
NVAX Novavax, Inc.	03/18/2019	10-K	10-K filing on 03/18/2019	View Form
NVAX Novavax, Inc.	11/07/2018	10-Q	10-Q filing on 11/07/2018	View Form
NVAX Novavax, Inc.	08/08/2018	10-Q	10-Q filing on 08/08/2018	View Form
NVAX Novavax, Inc.	05/09/2018	10-Q	10-Q filing on 05/09/2018	View Form
NVAX Novavax, Inc.	03/14/2018	10-K	10-K filing on 03/14/2018	View Form
NVAX Novavax, Inc.	11/07/2017	10-Q	10-Q filing on 11/07/2017	View Form
NVAX Novavax, Inc.	08/08/2017	10-Q	10-Q filing on 08/08/2017	View Form
NVAX Novavax, Inc.	05/08/2017	10-Q	10-Q filing on 05/08/2017	View Form
NVAX Novavax, Inc.	02/27/2017	10-K	10-K filing on 02/27/2017	View Form
NVAX Novavax, Inc.	11/09/2016	10-Q	10-Q filing on 11/09/2016	View Form
NVAX Novavax, Inc.	08/09/2016	10-Q	10-Q filing on 08/09/2016	View Form
NVAX Novavax, Inc.	05/05/2016	10-Q	10-Q filing on 05/05/2016	View Form
NVAX Novavax, Inc.	02/29/2016	10-K	10-K filing on 02/29/2016	View Form

Related Companies

Get NVAX Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

NVAX

Sector

P/E ratio

3.91x

23.75x

PEG ratio

--

-0.01x

P/B ratio

32.13x

1.83x

Price / LTM sales

1.10x

1.60x

Growth Metrics

NVAX

Sector

Revenue growth

-16.65%

4.85%

Earnings growth

-64.47%

11.11%

Revenue (5-year growth)

105.39%

6.45%

Earnings forecast

-$1.13

-$0.20

Profitability

NVAX

Sector

Profitability FY 2024

$484.2M

$3.6M

Return on invested capital

--

-30.98%

Return on assets

23.98%

-27.62%

Return on equity

--

-36.69%

Earnings Date

Last Earnings Date

Nov

6

Next Earnings Date

Feb

26

Estimated Next Earnings Date

Feb

5

Balance Sheet

NVAX

Sector

Total cash

$773.7M

$27.2M

Short term investments

$392.9M

$25.7M

Total assets

$1.6B

$79.7M

Long term debt

$251.1M

$4.1M

Stock Ideas

Buy

52

Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy or Sell?

Buy

56

Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy or Sell?

Buy

81

Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy or Sell?

Alerts

Buy

56

SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy or Sell?

Buy

72

KYMR alert for Dec 8

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

Buy or Sell?

Buy

62

PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Novavax, Inc. SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get NVAX Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?

Will Robinhood Win AI Investing?

Is Amazon an AI Stock?

Stock Ideas

Is NVDA Stock a Buy?

Is AAPL Stock a Buy?

Is GOOG Stock a Buy?

Alerts

SMX alert for Dec 8

KYMR alert for Dec 8

PRAX alert for Dec 8

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

Stocks by Sector

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS